A comprehensive view of Licensing / Royalty. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.
Indian Oil Corp. selects Lummus/Versalis cumene technology for its 440,000-tonne/year unit in Paradip, India; unit is part of Indian Oil's broader petrochemical and polymers expansion at the location
Published:
April 23, 2024
by PR Newswire
|
SABIC Fujian Petrochemicals selects KBR's phenol technology for 250,000-tone/year phenol plant slated for completion in fiscal 2026
Published:
April 22, 2024
by PR Newswire
|
Biopharma firm CureVac NV and the University of Texas MD Anderson Cancer Center partner to develop novel mRNA-based cancer vaccines; the collaboration will focus on creating vaccines for hematological and solid tumor indications
Published:
April 18, 2024
by Marketline - Deals
|
Novavax's updated non-mRNA COVID-19 vaccine, Nuvaxovid XBB.1.5, now available in UK for 2024 vaccination season following receipt of wholesale license and green book update
Published:
April 18, 2024
by Novavax Inc.
|
Medincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies; deal includes development of up to six injectables across multiple therapeutic areas
Published:
April 17, 2024
by Business Wire
|
Ask us about our Bioeconomy market view